Bulletin
Investor Alert

Revance Therapeutics Inc.

NAS: RVNC

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202924160/composite

$

13.43

Change

0.00 0.00%

Volume

Volume 15,740

Jan 21, 2022, 4:31 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202924160/composite

Previous close

$ 14.03

$ 13.43

Change

-0.60 -4.28%

Day low

Day high

$13.40

$14.17

Open
Open: 13.77

52 week low

52 week high

$12.34

$33.83

Open

Market cap

$1.01B

Average volume

768,011

P/E ratio

N/A

Rev. per Employee

$134,002

EPS

-4.48

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/rvnc

MarketWatch News on RVNC

  1. Revance Therapeutics started at buy with $50 stock price target at Stifel Nicolaus

    8:21 a.m. Jan. 29, 2019

    - Tomi Kilgore

  2. Revance to receive $30 mln upfront, potential milestone payments of up to $230.5 mln as part of license deal

    8:18 a.m. Dec. 4, 2018

    - Tomi Kilgore

  3. Revance's stock halted for news until 8:35 a.m. Eastern

    8:19 a.m. Dec. 4, 2018

    - Tomi Kilgore

  4. Revance Therapeutics enters China license agreement with Shanghai Fosun Pharmaceutical

    8:18 a.m. Dec. 4, 2018

    - Tomi Kilgore

  5. Allergan’s Stock Is Headed for a Face-Lift

    7:56 p.m. March 30, 2018

    - Barron's Online

  6. Charting the Market

    11:36 p.m. Dec. 8, 2017

    - Barron's Online

  7. Fine Lines: Why Allergan’s Botox Ain’t Beat

    10:41 a.m. Dec. 6, 2017

    - Barrons Blogs

  8. Allergan stock drops 3% after rival product's positive trial results

    12:10 p.m. Dec. 5, 2017

    - Emma Court

  9. Revance stock surges 32% on positive results for wrinkle injection in late-stage trial

    9:12 a.m. Dec. 5, 2017

    - Emma Court

  10. Revance Therapeutics stock price target raised to $32 vs. $22 at SunTrust Robinson

    7:57 a.m. Jan. 6, 2017

    - Ciara Linnane

  11. Here’s why U.S. investors might squeak past Brexit worries

    7:59 a.m. June 14, 2016

    - Barbara Kollmeyer

  12. Revance shares drop after crow's-feet treatment study fails

    3:48 p.m. June 13, 2016

    - Wallace Witkowski

  13. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/rvnc

Other News on RVNC

  1. Revance receives FDA guidance on wrinkle injection

    4:30 p.m. Jan. 18, 2022

    - Seeking Alpha

  2. Revance Therapeutics shares 7% higher after large CEO buy

    11:54 a.m. Nov. 30, 2021

    - Seeking Alpha

  3. 10-Q: REVANCE THERAPEUTICS, INC.

    4:26 p.m. Nov. 9, 2021

    - Edgar Online - (EDG = 10Q, 10K)

  4. Revance Therapeutics: Repricing Shares After A CRL

    2:58 p.m. Oct. 29, 2021

    - Seeking Alpha

  5. Revance Therapeutics slips further as bearish views pile up

    12:40 p.m. Oct. 25, 2021

    - Seeking Alpha

  6. Warning: RVNC is at high risk of performing badly

    3:36 a.m. Oct. 21, 2021

    - Seeking Alpha

  7. IONS, BTCS and NXTD among mid-day movers

    11:43 a.m. Oct. 18, 2021

    - Seeking Alpha

  8. Loading more headlines...
/news/pressrelease/company/us/rvnc

Press Releases on RVNC

  1. Revance Therapeutics Shareholder Alert

    7:52 p.m. Jan. 20, 2022

    - Newsfile Corp

  2. Revance Therapeutics Deadline Alert

    7:51 p.m. Jan. 19, 2022

    - Newsfile Corp

  3. Revance Therapeutics Shareholder Notice

    6:36 p.m. Jan. 18, 2022

    - Newsfile Corp

  4. Loading more headlines...

Rates »

Trending Tickers
  • /zigman2/quotes/207505872/composite DISH+1.05%
  • /zigman2/quotes/204151124/composite CURE-1.23%
  • /zigman2/quotes/214908404/composite GFL+1.15%
  • /zigman2/quotes/204236046/composite DUST+1.32%
  • /zigman2/quotes/200683073/composite FRC+0.90%
X
Powered by StockTwits
Link to MarketWatch's Slice.